Aardvark Therapeutics, Inc. Common Stock (AARD) Investor Relations Documents
Aardvark Therapeutics, Inc. Common Stock (AARD) investor relations documents from the company's IR site: 13 press releases. Read in-app with summaries. First-party data.
Investor relations documents — source: company IR site| Published | Type | Document |
|---|
| 2025-01-09 | Press release | Aardvark Therapeutics Appoints Renowned Biopharma Leaders Roy D. Baynes and Susan E. Graf to its Board of Directors |
| 2024-09-10 | Press release | Aardvark Therapeutics Expands Management Team with Two Key Hires |
| 2024-05-09 | Press release | Aardvark Therapeutics Announces $85 Million Oversubscribed Series C Financing |
| 2023-08-03 | Press release | Aardvark Therapeutics Announces Receipt of FDA Rare Pediatric Disease Designation for Prader-Willi Syndrome and Expands |
| 2023-06-20 | Press release | Aardvark Therapeutics Announces FDA Orphan Drug Designation Granted to ARD-101, a Novel Drug Candidate for Prader-Willi |
| 2023-06-12 | Press release | Aardvark Therapeutics Reports Positive Phase II Clinical Data for ARD-101 |
| 2022-02-02 | Press release | Aardvark Therapeutics, Inc., Announces the Initiation of Enrollment For Three Phase 2 Clinical Trials of Oral ARD-101 |
| 2022-01-10 | Press release | Aardvark Therapeutics, Inc., Announces it has been Invited to Present at the 40th Annual J.P. Morgan Health Care Confere |
| 2021-08-05 | Press release | Aardvark Therapeutics, Inc., Completes $29M Series B Funding Led by Sorrento Therapeutics and Including Existing Investo |
| 2021-03-01 | Press release | Sorrento Therapeutics and Scilex Holding, a Majority Owned Subsidiary, Have Entered Into an Exclusive Licensing Term She |
| 2020-12-02 | Press release | Aardvark Therapeutics, Inc., to Present at the 32nd Annual Piper Sandler Healthcare Conference |
| 2020-11-02 | Press release | Aardvark Therapeutics, Inc., Announces Poster Presentations at the 2020 Obesity Week Conference |
| 2020-10-15 | Press release | Aardvark Therapeutics, Inc., Announces Completion of First Cohort in Phase I for ARD-101 |
AARD overview · AARD earnings · AARD financials · AARD KPIs · AARD ownership · AARD peers · AARD filings
Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.